A promising therapeutic vaccination to suppress hepatitis B virus replication in immunosuppressed patients.
Imawari
Michio
M
D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use; D001323:Autoantibodies / Q000096:biosynthesis; D003713:Dendritic Cells / Q000276:immunology*; D006510:Hepatitis B Antibodies / Q000096:biosynthesis; D006514:Hepatitis B Surface Antigens / Q000276:immunology*; D017325:Hepatitis B Vaccines; D019259:Lamivudine / Q000627:therapeutic use; D051379:Mice; D008822:Mice, Transgenic; D014779:Virus Replication
D000998:Antiviral Agents; D001323:Autoantibodies; D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D017325:Hepatitis B Vaccines; D019259:Lamivudine